In January, they were overtaken by Novartis’ Pluvicto and Johnson & Johnson’s Tremfya; last month, it was Novo Nordisk’s Wegovy and J&J’s immunology med that leapfrogged over the previous ...

In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...

Semaglutide is available as Wegovy and Ozempic injections, and also as Rybelsus tablets. The study's findings indicate a potential link between these medications and a lower risk of dementia.

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...

This includes the likes of Ozempic, Mounjaro, Saxenda and Wegovy, which can sell for up to £269 a month. The drugs have proved popular with overweight Brits who want to rapidly lose weight and ...

Novo Nordisk's sought-after obesity therapy Wegovy has finally reached the UK and can be prescribed by NHS weight management services – but supplies are being carefully controlled as its ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

Weight loss drugs like Ozempic, Rybelsus, and Wegovy are trending—but are they right for you? Here’s what to consider before using them.